As of 21 Sept 2026, Symbiotec Pharmalab Ltd share price is ₹1,159.40. The stock opened at ₹1,159.40 and had closed at ₹1,093.25 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹933.80 and a high of ₹1,193.90. In terms of performance, Symbiotec Pharmalab Ltd share price has decreased by 3.63% over the past six months and has decreased by 0.25% over the last year.
SYMBIOTEC Stock Price Chart
Symbiotec Pharmalab Ltd Overview
About SYMBIOTEC
Symbiotec Pharmalab are a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across three platforms- organic chemistry, biotechnology and complex injectables.
Symbiotec Pharmalab Ltd Historical Performance
Symbiotec Pharmalab Ltd Fundamentals
Symbiotec Pharmalab Ltd Financials
| Indicator | No Data Available |
|---|---|
| Revenue | |
| EBITDA | |
| Net Profit | |
| EPS |
Symbiotec Pharmalab Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,058.60 |
| Resistance 1 (R1) | 1,116.95 |
| Pivot Point | 1,082.30 |
SYMBIOTEC Key Leadership Details
Last Updated: Feb 2021
| Name | Position |
|---|---|
| ANIL KUMAR SATWANI | Managing Director |
| SHANKAR GOPALAKRISHNAN | Nominee |
| VISWANATH VENKATA SUBRAHMANYA ANJANEYA CHIBROLU | Nominee |
Symbiotec Pharmalab Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,873.50+1.97% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,443.50+0.73% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,964.00+2.56% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Symbiotec Pharmalab Ltd today is ₹1,159.40 on NSE and ₹1,159.40 on BSE.
- The 52-week high of Symbiotec Pharmalab Ltd is ₹1,193.90, while the 52-week low is ₹933.80.
- The current market capitalisation of Symbiotec Pharmalab Ltd is approximately ₹7,025 crore.
- The P/E (Price-to-Earnings) ratio of Symbiotec Pharmalab Ltd is 0.00. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Symbiotec Pharmalab Ltd is 0.00. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Symbiotec Pharmalab Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for SYMBIOTEC on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Symbiotec Pharmalab Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Symbiotec Pharmalab Ltd comprises different categories of shareholders. As of Aug 2026, the shareholding is approximately 33.28% promoters, 15.54% FIIs, 27.52% DIIs, and 16.60% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
